文献速递妇科

子宫内膜异位症女性的处方阿片类药物使用模式:评估长期使用、日剂量及与苯二氮䓬类药物的联合使用

Patterns of Prescription Opioid Use in Women With Endometriosis: Evaluating Prolonged Use, Daily Dose, and Concomitant Use With Benzodiazepines.
PubMed 文献 · Obstet Gynecol · 2019-01-01

一项回顾性分析比较了2006年1月至2016年12月间诊断子宫内膜异位症的18-49岁女性与按年龄、地区、种族、保险支付方和计划类型匹配的对照组女性。子宫内膜异位症组相比对照组更可能填写阿片类药物处方、高日剂量处方及与苯二氮䓬类药物联合处方,且长期联合使用概率更高。

要点

  • 子宫内膜异位症组79.3%填写阿片处方,对照组24.2%,调整RR 2.91(95%CI 2.87-2.94)。
  • 子宫内膜异位症组45.6%填写≥50吗啡毫克当量处方,对照组9.7%,调整RR 4.07(95%CI 3.98-4.16)。
  • 子宫内膜异位症组10.1%有阿片与苯二氮䓬联合处方,对照组3.5%,调整RR 1.95(95%CI 1.88-2.03)。

核心结论

  • 子宫内膜异位症女性相比无此病的女性,长期使用阿片类药物及与苯二氮䓬类药物联合使用的概率更高。

研究设计与样本

  • 对Clinformatics Datamart数据库进行回顾性分析,纳入2006年1月至2016年12月诊断子宫内膜异位症的18-49岁女性,与按年龄、地区、种族、保险支付方和计划类型匹配的对照组女性比较。
  • 研究样本包括53,847例子宫内膜异位症患者和107,694例对照组患者,平均年龄38岁,62.4%为白人,51.6%居住在南方。
  • 采用t检验和χ统计进行描述性分析,多变量回归分析得出调整相对危险度(RR)及95%CI。

主要发现

  • 子宫内膜异位症组42,705例(79.3%)填写阿片类药物处方,对照组26,106例(24.2%),调整RR 2.91(95%CI 2.87-2.94)。
  • 子宫内膜异位症组24,544例(45.6%)填写剂量≥50吗啡毫克当量的处方,对照组10,463例(9.7%),调整RR 4.07(95%CI 3.98-4.16)。
  • 子宫内膜异位症组8,013例(14.9%)填写剂量≥100吗啡毫克当量的处方,对照组3,582例(3.3%),调整RR 3.56(95%CI 3.43-3.70)。
  • 子宫内膜异位症组5,453例(10.1%)有阿片与苯二氮䓬联合处方,对照组3,711例(3.5%),调整RR 1.95(95%CI 1.88-2.03)。
  • 子宫内膜异位症组1,596例(3.0%)联合使用至少30天,对照组1,265例(1.2%),调整RR 1.43(95%CI 1.34-1.52);子宫内膜异位症组875例(1.6%)联合使用至少90天,对照组777例(0.7%),调整RR 1.27(95%CI 1.17-1.37)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine opioid use, opioid prescribing patterns, and timing of the first opioid prescription in endometriosis patients compared with matched women in the control group without endometriosis. METHODS: We conducted a retrospective analysis of the Clinformatics Datamart database. Women diagnosed with endometriosis from January 2006 through December 2016 and aged 18-49 years were compared with women in the control group matched on age, region, race, insurance payer, and plan type. Key outcomes included: filled prescription for an opioid, multiple opioid prescriptions, number of days' supply, daily dose (morphine milligram equivalents), and concomitant opioid and benzodiazepine prescriptions. Cohorts were descriptively analyzed using t- and χ statistics and multivariable regression analyses yielded adjusted relative risk (RR) ratios and 95% CI. RESULTS: The study sample included 53,847 endometriosis patients and 107,694 patients in the control group. The mean age was 38 years, 62.4% of patients were white, and 51.6% lived in the South. Women in the endometriosis case group, compared with women in the control group, were more likely to fill an opioid prescription (42,705 [79.3%] women in the case group vs 26,106 [24.2%] women in the control group; adjusted RR ratio 2.91; 2.87-2.94), had higher likelihood of filling prescriptions with a dose of 50 morphine milligram equivalents or more (24,544 [45.6%] vs 10,463 [9.7%]; adjusted RR ratio 4.07; 3.98-4.16) or 100 morphine milligram equivalents or more (8,013 [14.9%] vs 3,582 [3.3%]; adjusted RR ratio 3.56; 3.43-3.70). Women in the case group were more likely to have concomitant opioid and benzodiazepine prescriptions (5,453 [10.1%] vs 3,711 [3.5%]; adjusted RR ratio 1.95; 1.88-2.03) and to have used these drugs concurrently for at least 30 days (1,596 [3.0%] vs 1,265 [1.2%]; adjusted RR ratio 1.43; 1.34-1.52) or at least 90 days (875 [1.6%] vs 777 [0.7%]; adjusted RR ratio 1.27; 1.17-1.37). Similar results were obtained after excluding opioid prescriptions received during a 30-day postsurgery window. CONCLUSION: Women with endometriosis had higher probabilities of prolonged use of opioids and concomitant use with benzodiazepines compared with women without this condition. FUNDING SOURCE: This study was funded by AbbVie, Inc.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Lamvu G, Soliman AM, Manthena SR, et al. Patterns of Prescription Opioid Use in Women With Endometriosis: Evaluating Prolonged Use, Daily Dose, and Concomitant Use With Benzodiazepines. Obstet Gynecol. 2019. PMID: 31135725. doi:10.1097/AOG.0000000000003267

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。